Paydirt
SR
Insider

Saira Ramasastry

Director

Saira Ramasastry (Director) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Mirum Pharmaceuticals, Inc. (MIRM). The largest single filing was $400K of MIRM (5,000 sh × $80.00, as filed), executed Dec 22 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.8M
shares × price, as filed
Last traded
Jun 1
Filed Jun 2

Median ADV $83.1M across their filed names

Open performance
Volume by month
$1.3M$658K$0Oct 2024Apr 2025Oct 2025Apr 2026Jun 2025 · sells $378KSep 2025 · sells $1.3MDec 2025 · sells $400KJan 2026 · sells $182KFeb 2026 · sells $204KMar 2026 · sells $182KApr 2026 · sells $194KMay 2026 · sells $219KJun 2026 · sells $398K
Buys $0 Sells $3.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names
MIRM Mirum Pharmaceuticals, Inc. MIRM · 0 buys · 9 sells 9 filings
Recent filings
MIRMSALE Mirum Pharmaceuticals, Inc. View filing → $378K
8,203 sh across 2 lots
Exec Jun 2 2025
Filed Jun 4 2025 · 5:30 PM ET